Home RVL Pharmaceuticals

RVL Pharmaceuticals

acquired
IPO Delisting
Drug Developer

Basic Information

Osmotica Pharmaceutical is a global specialty pharmaceutical company with a history of successfully developing commercial drugs, focusing on the development and commercialization of specific products, targeting underserved patient populations. The company leverages its proprietary osmotic technology platform to develop and commercialize high-quality pharmaceutical products in collaboration with strategic partners.
RVL Pharmaceuticals plc
NewJersey,United States of America
101~500 people
January 01, 2000
medicalinfo@osmotica.com